GTC Biotherapeutics (fka GTCB)

[croumagnon]

Re: Small shareholders act against Genzyme bid

"The situation does point out our vulnerabilities in GTCB. The PPS action over the last eight days suggests to me someone is trying to hold the PPS down basically by selling into any buy orders."

I agree with you 100%. This is one of the dangers that could limit the future upside of GTCB, namely some sort of an arranged takeover by Genzyme or some other large biotech company. Clearly the capping at $1.2 is disturbing and seems to point in that direction. They keep the price from exploding for a long time and then come in with an offer of say $2 that shareholders will be glad to take. I have seen that scenario play out before with Imatron a few years back. At the time it was GE that was doing the dirty games and then they bought them out on the cheap...